A Descriptive Study of Patients Suspected With Infection in the Emergency Department, With a Special Focus on Infection With Unknown Origin.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 966
- Locations
- 1
- Primary Endpoint
- Diagnosis after 2 days
Study Overview
Brief Summary
Patients suspected with infection is one of the major groups, who are admitted to the Danish Emergency Departments (ED). Currently, there is no overall description of the distribution of these infections. The aim of this study is to characterize ED patients with a suspected infection whereby the focus of the infection is of an unknown origin.
Detailed Description
Bacteria resistant to antibiotics are associated with high antibiotic consumption and are identified by the World Health Organisation as a major public health threat. Despite efforts to optimize antibiotic consumption in Denmark, the total consumption in the hospital sector increased from 2009-2018 and the incidence of multi-resistance bacteria (MRB) is increasing. A Danish multicenter study has shown that every 20th patient in the emergency department has MRB. Patients with an infection of unknown origin tend to be prescribed a broad-spectrum antibiotic, as physicians endeavour to target probable origins in the body. The uncertainty associated with the diagnosis may lead to an overconsumption of antibiotics, which contributes to increased development of resistant bacteria and threatens future treatment options.
The aim of this study is to characterize patients admitted to the ED suspected with infection. The study will have three objectives:
- To describe the distribution of ED infections according to the registered diagnosis in the medical record compared to a clinical expert panel assessment
- To identify clinically relevant information available at admission associated with a patients infection of unknown origin.
- To investigate the association between an adverse event and clinically relevant information for patients with infection of unknown origin
The investigators' hypothesis is that with an improvement of knowledge about patients with an infection of unknown origin, a more accurate diagnosis can be made leading to a more appropriate antibiotic therapy and contributing to the fight against resistance to antibiotics.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults admitted to the ED will be invited to participate in the study, if the physician, receiving the patient, suspect the patient has an infection (e.g. indication for blood culture).
Exclusion Criteria
- •If the attending physician considers that participation will delay a life-saving treatment or patient needs direct transfer to the intensive care unit.
- •Admission within the last 14 days
- •Verified COVID-19 disease within 14 days before admission
- •Pregnant women
- •Severe immunodeficiencies: Primary immunodeficiencies and secondary immunodeficiencies (HIV positive CD4 <200, Patients receiving immunosuppressive treatment (ATC L04A), Corticosteroid treatment (>20 mg/day prednisone or equivalent for >14 days within the last 30 days), Chemotherapy within 30 days)
Outcomes
Primary Outcomes
Diagnosis after 2 days
Time Frame: 48 hours after admission emergency department
Diagnosis code of patient (registered medical record and clinical expert panel assessment)
Secondary Outcomes
- In-hospital mortality(within 60 days from admission to the emergency department)
- Intensive care unit treatment(within 60 days from admission to the emergency department)
- 30-days mortality(within 30 days from admission to the emergency department)
- Readmission(within 30 days from day of discharge)
- Length of stay(within 60 days from admission to the emergency department)
- Diagnose code at hospital discharge(within 60 days from admission to the emergency department)